Monoclonal antibodies are laboratory-made molecules designed to serve as substitute antibodies that can restore, enhance, or mimic the immune system's attack on cancer cells. They can be engineered to bind specifically to cancer cell antigens, marking them for destruction by other immune cells. Examples include Rituximab and Trastuzumab.
